Through clinical feature analysis, serum CEA level was linked to lymph node metastasis and molecular subtypes, while serum CA15-3 level was linked to TNM stage and lymph node metastasis. Here, CEACAM5 is linked to metastatic malignant neoplasm in the lymph nodes.